News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Provalis (PVLS) Signs Vaccine Option Agreement With Aventis Pasteur



10/19/2005 5:12:26 PM

Provalis plc (LSE:PRO) (Nasdaq:PVLS), the Medical Diagnostics and Pharmaceuticals Group, today announces that it has signed an option agreement with Aventis Pasteur, the vaccines business of the sanofi-aventis Group, for the development of vaccine candidates to prevent streptococcus pneumoniae infection.

Read at Prime Zone


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES